With Limits Created By China's New Pharmacopoeia, What's Next For Vaccine Manufacturers?
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China is expected to be the world's largest vaccine market by 2020, and every vaccine maker is trying to increase their presence to gain market share. However, the new Chinese Pharmacopoeia might put these efforts to an end and almost all vaccines from multinational companies may have to withdraw from China if they fail to comply with new standards